Prof. Andrew Wyllie is Head of the Department of Pathology, Cambridge University, United Kingdom and an Honorary Consultant, Addenbrooke's Hospital in Cambridge. Prof. Wyllie trained at the University of Aberdeen where he received his BSc, MB, ChB and PhD In the 1970s and 1980s, Dr. Wyllie coined the term "apoptosis", outlined the cardinal characteristics of this program of cell death and articulated the significance of apoptosis in human disease. The conceptual breakthrough provided by Dr. Wyllie and his subsequent championing of this field have led to numerous presentations at prestigious international symposia. He has been an Editorial Board Member of the Journal of Pathology, Member of the Advisory Editorial Board for the International Review of Experimental Pathology, Editor (Pathology Section) British Journal of Cancer and has been a Member of the Editorial Academy of the International Journal of Oncology since 1992. Among Prof. Wyllie's honours are the Bertner Award, MD Anderson Cancer Centre, University of Texas (1994), Fellow of the Royal Society (1995), Hans Bloemendal Award, University of Nijmegen (1998) and Founder Member, British Academy of Medical Science.
Andrew H. Wyllie
MB CHB PHD FRCPATH FRSE FRS
Canada Gairdner International Award
In recognition of their pioneering contribution to our understanding of apoptosis.
Head, Department of Pathology, Cambridge University, Cambridge, UK